7 results
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Norepinephrine Reuptake Inhibitors ... Cymbalta) - GAD, MDD, Diabetic ... Serotonin-Norepinephrine Reuptake Inhibitors ... #Pharmacology # ... Psychiatry #FDA
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... events TZDs DPP-4 inhibitors ... SGLT2 inhibitors ... adverse CV events, Improved ... endocrinology #dm2
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... Canagliflozin) being approved ... Ertugliflozin) being approved ... #Pharmacology # ... Medications #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... #Mellitus #DM2 ... #Inpatient #Medications ... #pharmacology #
Neurological Side Effects of Antipsychotic Drugs
Acute dystonia - Spasm of muscles of tongue, face, neck, back
Young, antipsychotic ... discontinuation VMAT2 inhibitors ... deutetrabenazine are FDA-approved ... #Drugs #Medications ... #SideEffects #pharmacology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... different than other medications ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Lidocaine 5% Patch (Lidoderm) 
Medicare Covered Indications 
1. Post-herpetic neuralgia pain 
2. Diabetic peripheral neuropathy 
3.
Diabetic peripheral ... : PHN pain, DM neuropathy ... is technically approved ... Patch #Lidoderm #Pharmacology ... #Indications